Creo Medical (GB:CREO) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Creo Medical’s CFO Richard Rees executed a ‘Bed and ISA’ transaction, selling and repurchasing over 174,000 company shares, while his associate Rachel Rees acquired the remaining shares. This strategic move reflects internal confidence in the medical device firm’s focus on advanced energy solutions for surgical endoscopy.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.